Drugs / HAC1

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01177202 Sep 2010 → May 2011 swine influenza Fraunhofer, Center for Molecular Biotechnology Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as HAC1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01177202 ↗
Known as HAC1 Vaccine “Biological: HAC1 Vaccine” NCT01177202 ↗
Modality Vaccine “A subunit influenza vaccine, HAC1, based on recombinant hemagglutinin” PMID 24126211 ↗ Oct 2013